450 related articles for article (PubMed ID: 1858971)
21. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
22. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Young RJ; Gilson RT; Elston DM
Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
24.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
25. IgM anti-phenolic glycolipid-I antibody measurements from skin-smear sites: correlation with venous antibody levels and the bacterial index.
Butlin CR; Soares D; Neupane KD; Failbus SS; Roche PW
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):465-8. PubMed ID: 9465156
[TBL] [Abstract][Full Text] [Related]
26. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
27. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
28. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
29. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
30. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
31. Relationships between PGL-1 antigen in serum, tissue and viability of Mycobacterium leprae as determined by mouse footpad assay in multibacillary patients during short-term clinical trial.
Chanteau S; Cartel JL; Perani E; N'Deli L; Roux J; Grosset JH
Lepr Rev; 1990 Dec; 61(4):330-40. PubMed ID: 2280654
[TBL] [Abstract][Full Text] [Related]
32. Association of IgG and IgM antibodies to phenolic glycolipid-1 antigen of Mycobacterium leprae with disease parameters in multibacillary leprosy patients.
Lyons NF; Shannon EJ; Ellis BP; Naafs B
Lepr Rev; 1988 Mar; 59(1):45-52. PubMed ID: 3294540
[No Abstract] [Full Text] [Related]
33. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
34. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
Han XY; Quintanilla M
J Clin Microbiol; 2015 Nov; 53(11):3695-8. PubMed ID: 26311856
[TBL] [Abstract][Full Text] [Related]
35. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
36. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
37. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
[TBL] [Abstract][Full Text] [Related]
38. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy.
Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456
[TBL] [Abstract][Full Text] [Related]
39. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
[TBL] [Abstract][Full Text] [Related]
40. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
